MedPath

Cortisone

Generic Name
Cortisone
Drug Type
Small Molecule
Chemical Formula
C21H28O5
CAS Number
53-06-5
Unique Ingredient Identifier
V27W9254FZ

Overview

A naturally occurring glucocorticoid. It has been used in replacement therapy for adrenal insufficiency and as an anti-inflammatory agent. Cortisone itself is inactive. It is converted in the liver to the active metabolite hydrocortisone. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726)

Indication

肾上腺皮质激素类药。主要用于肾上腺皮质功能减退症及垂体功能减退症的替代治疗,亦可用于过敏性和炎症性疾病;局部外用于治疗虹膜睫状体炎、虹膜炎、角膜炎、过敏性结膜炎等。也可用于治疗角膜移植后的排斥反应和眼科手术后的炎症反应。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2023/10/13
Not Applicable
Completed
2018/11/30
Phase 4
UNKNOWN
Federico II University
2018/07/09
Phase 2
Completed
2016/09/28
Not Applicable
Completed
2016/08/04
Not Applicable
Completed
2015/12/24
Phase 4
Completed
Scott and White Hospital & Clinic
2014/07/21
Not Applicable
Recruiting
2014/03/19
N/A
Completed
Northern Orthopaedic Division, Denmark
2011/10/06
Phase 3
UNKNOWN
Federal University of São Paulo
2010/06/30
Phase 2
Completed
Technical University of Munich

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.